AML MATTERS – Multidisciplinary Approach to Testing & Diagnosis, Evaluation of Risk, and Personalized Treatment Selection

Pathologists, laboratory professionals, and other members of the multidisciplinary cancer care team face challenges in managing acute myeloid leukemia (AML), which is associated with significant morbidity and mortality rates that affect many patients in the United States. ASCP is a long-standing, proud partner in collaborations designed to meet the needs of multidisciplinary care teams on the optimal testing, diagnosis, evaluation of risk, and personalized treatment of AML.